IBD Registry in a Sub-Saharan African Population
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorUniversity of Zimbabwe
About this trial
The investigators intend to establish a prospective registry of patients diagnosed with inflammatory bowel disease at Parirenyatwa hospital in Harare, Zimbabwe. The study will periodically collect data on disease phenotype, disease course, and clinical management, and will biobank stool specimens and germline DNA. One relative, and an individual from the same neighbourhood will be also be recruited for a nested case-control study into risk factors of inflammatory bowel disease in this population.
Eligibility criteria
Qualifiers
Cases
Any patient with confirmed inflammatory bowel disease
Onset of disease ≥3 months ago.
Controls
Disqualifiers
Cases
Controls
Suspected inflammatory bowel disease
Unexplained gastrointestinal symptoms including diarrhoea, vomiting, chronic abdominal pain, weight loss, rectal bleeding, and recent change in bowel habit.
Trial design
Treatments tested in this trial
- No intervention
Treatment groups
100 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov